Lapatinib Active Not Recruiting Phase 1 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02073916T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
NCT01300962Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer